Skip to main content
NIH funding notice PAR-18-263

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)

Closed on May 28, 2019.

Posted
November 29, 2017
Close date
May 28, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,199,400 in first-year total cost, median $1,099,700.

Most frequent study sections

  1. Special Emphasis Panel[ZGM1 RCB-9 (IN)]2

Most frequent institutions

  1. CLEMSON UNIVERSITY1
  2. UNIVERSITY OF HAWAII AT MANOA1
Competing awards under PAR-18-263 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT)1P30GM131959-01VYAVAHARE, NAREN RCLEMSON UNIVERSITY, SC$1,156,024ZGM1
2019IBR-COBRE Phase III1P30GM131944-01WARD, WILLIAM SUNIVERSITY OF HAWAII AT MANOA, HI$1,043,376ZGM1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.